Spectrum Pharmaceuticals/ US84763A1088 /
| 2023-07-31 10:00:00 PM | Chg. - | Volume | Bid1:50:09 AM | Ask1:50:09 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.0300USD | - | 5.93 mill. Turnover: 5.61 mill. |
1.0200Bid Size: - | 1.0400Ask Size: - | 211.42 mill.USD | - | - |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.41 USD | -59.80% |
| EPS Diluted: | -0.41 USD | -59.80% |
| Revenues per Share: | 0.05 USD | - |
| Book Value per Share: | 0.14 USD | -49.40% |
| Cash Flow per Share: | -0.47 USD | -29.96% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 10.11 USD | - |
| Net Income: | -75.40 USD | -52.47% |
| Operating Cash Flow: | -96.99 USD | - |
| Cash and Cash Equivalents: | 40.37 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 20.91 | 7.48 |
| P/BV ratio: | 7.58 | 2.71 |
| P/CF Ratio: | -2.18 | -0.78 |
| PEG: | 0.04 | - |
| Earnings Yield: | -39.81% | -111.26% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 211.42 mill. USD | 75.65 mill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 205.26 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | -718.78% |
| Net Profit Margin: | -745.51% |
| Return on Equity: | -270.37% |
| Return on Assets: | -72.97% |
Financial Strength
| Liquidity I / Cash Ratio: | 94.57% |
| Liquidity II / Quick Ratio: | 125.02% |
| Liquidity III / Current Ratio: | 236.64% |
| Debt / Equity Ratio: | 270.55% |
| Dynam. Debt / Equity Ratio: | -77.79% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2022-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
